These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
84. A lethal disease model for hantavirus pulmonary syndrome in immunosuppressed Syrian hamsters infected with Sin Nombre virus. Brocato RL; Hammerbeck CD; Bell TM; Wells JB; Queen LA; Hooper JW J Virol; 2014 Jan; 88(2):811-9. PubMed ID: 24198421 [TBL] [Abstract][Full Text] [Related]
85. Andes virus and first case report of Bermejo virus causing fatal pulmonary syndrome. Padula P; Della Valle MG; Alai MG; Cortada P; Villagra M; Gianella A Emerg Infect Dis; 2002 Apr; 8(4):437-9. PubMed ID: 11971782 [TBL] [Abstract][Full Text] [Related]
86. Juquitiba-like hantavirus from 2 nonrelated rodent species, Uruguay. Delfraro A; Tomé L; D'Elía G; Clara M; Achával F; Russi JC; Arbiza Rodonz JR Emerg Infect Dis; 2008 Sep; 14(9):1447-51. PubMed ID: 18760017 [TBL] [Abstract][Full Text] [Related]
87. Acute Sin Nombre hantavirus infection without pulmonary syndrome, United States. Kitsutani PT; Denton RW; Fritz CL; Murray RA; Todd RL; Pape WJ; Wyatt Frampton J; Young JC; Khan AS; Peters CJ; Ksiazek TG Emerg Infect Dis; 1999; 5(5):701-5. PubMed ID: 10511527 [TBL] [Abstract][Full Text] [Related]
92. Human Whitmer SLM; Whitesell A; Mobley M; Talundzic E; Shedroff E; Cossaboom CM; Messenger S; Deldari M; Bhatnagar J; Estetter L; Zufan S; Cannon D; Chiang CF; Gibbons A; Krapiunaya I; Morales-Betoulle M; Choi M; Knust B; Amman B; Montgomery JM; Shoemaker T; Klena JD Lancet Reg Health Am; 2024 Sep; 37():100836. PubMed ID: 39100240 [TBL] [Abstract][Full Text] [Related]
93. Update: hantavirus pulmonary syndrome--United States, 1993. Centers for Disease Control and Prevention (CDC) MMWR Morb Mortal Wkly Rep; 1993 Oct; 42(42):816-20. PubMed ID: 8413170 [TBL] [Abstract][Full Text] [Related]
94. Hantavirus infection prevalence in wild rodents and human anti-hantavirus serological profiles from different geographic areas of South Brazil. Raboni SM; Delfraro A; de Borba L; Teixeira BR; Stella V; de Araujo MR; Carstensen S; Rubio G; Maron A; Lemos ER; D'Andrea PS; Duarte dos Santos CN Am J Trop Med Hyg; 2012 Aug; 87(2):371-8. PubMed ID: 22855773 [TBL] [Abstract][Full Text] [Related]
95. Active and passive vaccination against hantavirus pulmonary syndrome with Andes virus M genome segment-based DNA vaccine. Custer DM; Thompson E; Schmaljohn CS; Ksiazek TG; Hooper JW J Virol; 2003 Sep; 77(18):9894-905. PubMed ID: 12941899 [TBL] [Abstract][Full Text] [Related]
96. The Syrian hamster model of hantavirus pulmonary syndrome. Safronetz D; Ebihara H; Feldmann H; Hooper JW Antiviral Res; 2012 Sep; 95(3):282-92. PubMed ID: 22705798 [TBL] [Abstract][Full Text] [Related]
97. Hantavirus pulmonary syndrome in Latin America. Pini N Curr Opin Infect Dis; 2004 Oct; 17(5):427-31. PubMed ID: 15353962 [TBL] [Abstract][Full Text] [Related]
98. Genetic identification of a new hantavirus causing severe pulmonary syndrome in Argentina. López N; Padula P; Rossi C; Lázaro ME; Franze-Fernández MT Virology; 1996 Jun; 220(1):223-6. PubMed ID: 8659118 [TBL] [Abstract][Full Text] [Related]
99. Sin Nombre virus-specific immunoglobulin M and G kinetics in hantavirus pulmonary syndrome and the role played by serologic responses in predicting disease outcome. MacNeil A; Comer JA; Ksiazek TG; Rollin PE J Infect Dis; 2010 Jul; 202(2):242-6. PubMed ID: 20521946 [TBL] [Abstract][Full Text] [Related]
100. Progress on the Prevention and Treatment of Hantavirus Disease. Brocato RL; Hooper JW Viruses; 2019 Jul; 11(7):. PubMed ID: 31277410 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]